 |
2 April 2012 - Rhenovia to BioCentury: Simultaneous launch of Orphan Disease Biosimulation Platforms and 2nd Round Table for Investors
Rhenovia Pharma SAS (Mulhouse, France) and Rhenovia Development Inc. (Cambridge, MA, USA)
April 2nd, 2012 In an interview to BioCentury Serge Bischoff, PhD, President & CEO reveals the simultaneous launch of new biosimulation drug discovery programs for Huntington Disease and Duchenne muscular dystrophies as well as of a second round table of fund raising by external investors of $4 million.
Thank you for contacting Dr. Serge Bischoff, at info@rhenovia.com
|
|
|
